Boundless Bio Common Stock Technical Analysis
| BOLD Stock | USD 1.16 0.00 0.00% |
As of the 17th of February 2026, Boundless Bio shows the Mean Deviation of 2.12, risk adjusted performance of (0.01), and Standard Deviation of 2.97. Boundless Bio Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Boundless Bio Common standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Boundless Bio Common is priced correctly, providing market reflects its regular price of 1.16 per share. Given that Boundless Bio is a hitting penny stock territory we recommend to closely look at its jensen alpha.
Boundless Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Boundless, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BoundlessBoundless | Build AI portfolio with Boundless Stock |
Boundless Bio Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 4.0 | Buy | 3 | Odds |
Most Boundless analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Boundless stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Boundless Bio Common, talking to its executives and customers, or listening to Boundless conference calls.
Will Biotechnology sector continue expanding? Could Boundless diversify its offerings? Factors like these will boost the valuation of Boundless Bio. Projected growth potential of Boundless fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Boundless Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Boundless Bio Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio's value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Boundless Bio's market value can be influenced by many factors that don't directly affect Boundless Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Boundless Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Boundless Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Boundless Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Boundless Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Boundless Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Boundless Bio.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Boundless Bio on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Boundless Bio Common or generate 0.0% return on investment in Boundless Bio over 90 days. Boundless Bio is related to or competes with Q32 Bio, NextCure, Plus Therapeutics, Intensity Therapeutics, Iterum Therapeutics, AN2 Therapeutics, and Pluri. Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene ther... More
Boundless Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Boundless Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Boundless Bio Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 4.24 |
Boundless Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boundless Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Boundless Bio's standard deviation. In reality, there are many statistical measures that can use Boundless Bio historical prices to predict the future Boundless Bio's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | (0.17) |
Boundless Bio February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 2.12 | |||
| Coefficient Of Variation | (4,869) | |||
| Standard Deviation | 2.97 | |||
| Variance | 8.8 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 4.24 | |||
| Skewness | 0.8989 | |||
| Kurtosis | 2.59 |
Boundless Bio Common Backtested Returns
At this point, Boundless Bio is very risky. Boundless Bio Common secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Boundless Bio Common, which you can use to evaluate the volatility of the firm. Please confirm Boundless Bio's Standard Deviation of 2.97, risk adjusted performance of (0.01), and Mean Deviation of 2.12 to double-check if the risk estimate we provide is consistent with the expected return of 0.0115%. The firm shows a Beta (market volatility) of 0.42, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Boundless Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Boundless Bio is expected to be smaller as well. Boundless Bio Common right now shows a risk of 2.9%. Please confirm Boundless Bio Common potential upside, as well as the relationship between the accumulation distribution and day typical price , to decide if Boundless Bio Common will be following its price patterns.
Auto-correlation | -0.8 |
Almost perfect reverse predictability
Boundless Bio Common has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Boundless Bio time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Boundless Bio Common price movement. The serial correlation of -0.8 indicates that around 80.0% of current Boundless Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.8 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Boundless Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Boundless Bio Common Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Boundless Bio Common volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Boundless Bio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Boundless Bio Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Boundless Bio Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Boundless Bio Common price pattern first instead of the macroeconomic environment surrounding Boundless Bio Common. By analyzing Boundless Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Boundless Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Boundless Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
Boundless Bio February 17, 2026 Technical Indicators
Most technical analysis of Boundless help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Boundless from various momentum indicators to cycle indicators. When you analyze Boundless charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 2.12 | |||
| Coefficient Of Variation | (4,869) | |||
| Standard Deviation | 2.97 | |||
| Variance | 8.8 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 16.75 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 4.24 | |||
| Skewness | 0.8989 | |||
| Kurtosis | 2.59 |
Boundless Bio February 17, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Boundless stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 1.15 | ||
| Day Typical Price | 1.15 | ||
| Price Action Indicator | 0.02 | ||
| Market Facilitation Index | 0.03 |
Complementary Tools for Boundless Stock analysis
When running Boundless Bio's price analysis, check to measure Boundless Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio is operating at the current time. Most of Boundless Bio's value examination focuses on studying past and present price action to predict the probability of Boundless Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio's price. Additionally, you may evaluate how the addition of Boundless Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |